- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Natural Killer Cell-Mediated Cellular Therapy of Hematological Malignancies ; volume:1 ; number:3 ; day:1 ; month:9 ; year:2019 ; pages:134-141 ; date:9.2019
Clinical hematology international ; 1, Heft 3 (1.9.2019), 134-141, 9.2019
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.2991/chi.d.190623.001
- URN
-
urn:nbn:de:101:1-2404301318274.225218856546
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
09.02.2026, 8:29 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sahin, Ugur
- Beksac, Meral
- SpringerLink (Online service)
Other Objects (12)
Cellular immunotherapy for refractory hematological malignancies
Deubiquitinases in hematological malignancies
Rac GTPases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting immune checkpoints in hematological malignancies
IL-31, itch and hematological malignancies
Targeting splicing for hematological malignancies therapy
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
Targeting posttranslational modifications to treat hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
Deubiquitinases in hematological malignancies
Rac GTPases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting immune checkpoints in hematological malignancies
IL-31, itch and hematological malignancies
Targeting splicing for hematological malignancies therapy
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
Targeting posttranslational modifications to treat hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
Deubiquitinases in hematological malignancies
Rac GTPases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting immune checkpoints in hematological malignancies
IL-31, itch and hematological malignancies
Targeting splicing for hematological malignancies therapy
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting